Abstract
Introduction: Surgeons frequently struggle with determining which patients will benefit from liver transplantation. This is especially true in the case of frail patients. Until now, there were no quantitative and objective measures of frailty among transplant patients. With this work, we introduce the concept of central sarcopenia as a proxy measure for patient frailty and as a powerful predictor of post-liver transplant mortality. Methods: We identified n=207 deceased-donor liver recipients transplanted at the University of Michigan between 01/01/2002 and 12/31/2008 who had a CT scan of the abdomen in the peri-transplant period.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
